Jonathan Kessler

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study”.

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231210675

N/A

0.296DataRank · unranked

5 citations

Colt A. Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Pei‐Cheng Lin, Helen Chang +17 more

Bioinspired intratumoral infusion port catheter improves local drug delivery in the liver

Scientific Reports(2024)10.1038/s41598-024-79694-4

N/A

0.241DataRank · unranked

4 citations

Imran Shair Mohammad, Anup Kumar Patel, Jonathan Kessler, Cherng Chao, Bo Liu +5 more

Phase II Trial of Lung Chemoembolization

Journal of Vascular and Interventional Radiology(2023)10.1016/j.jvir.2023.08.006

N/A

0.201DataRank · unranked

2 citations

Ravi Salgia, Thomas C. Waddington, Erminia Massarelli, John J. Park, Jonathan Kessler +4 more